Ochratoxin A and Clear Cell Renal Cell Carcinoma: Exploring Potential Molecular Links Through Network Toxicology and

Chenjie Huang1, Lulu Wei1, Wenqi Yuan1

  • 1School of Clinical Medicine, Jiangxi University of Chinese Medicine, Nanchang 330004, China.

Insights

Ochratoxin A (OTA) exposure may drive clear cell renal cell carcinoma (ccRCC) through specific molecular pathways. This study identified key genes like IGFBP3 and ITGA5 involved in OTA-induced ccRCC development.

Area of Science:

  • Toxicology and Oncology
  • Bioinformatics and Computational Biology

Background:

  • Ochratoxin A (OTA) is a common food contaminant linked to clear cell renal cell carcinoma (ccRCC).
  • The precise molecular mechanisms connecting OTA exposure to ccRCC remain largely unelucidated.

Purpose of the Study:

  • To systematically investigate the molecular mechanisms underlying OTA-associated ccRCC using integrated network toxicology, machine learning, and molecular docking.
  • To identify key genes and pathways involved in the pathogenesis of ccRCC induced by OTA.

Main Methods:

  • Utilized Gene Expression Omnibus (GEO) datasets for differential expression and weighted gene co-expression network analysis (WGCNA).
  • Integrated network toxicology, machine learning (glmBoost + RF, SHAP), and molecular docking.
  • Performed Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses.

Main Results:

  • Identified 56 overlapping genes between ccRCC and OTA targets, enriched in extracellular matrix remodeling, immune microenvironment, and metabolism.
  • Extracted nine key genes, with IGFBP3 and ITGA5 identified as principal drivers using SHAP analysis.
  • Validated core genes' differential expression, cell-type specificity, and diagnostic efficacy; predicted stable OTA-protein interactions.

Conclusions:

  • Established potential molecular links between OTA exposure and ccRCC pathogenesis.
  • Highlighted IGFBP3 and ITGA5 as critical drivers in OTA-induced ccRCC.
  • Provided a basis for future experimental validation and therapeutic strategies.